Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > $20 million bought deal at $0.58.....who's winning here..LOL
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(82)
•••
Comment by flad101on May 12, 2021 8:18am
130 Views
Post# 33181133

RE:RE:RE:RE:RE:RE:RE:RE:$20 million bought deal at $0.58.....who's winning here..LOL

RE:RE:RE:RE:RE:RE:RE:RE:$20 million bought deal at $0.58.....who's winning here..LOLHey Aaron she is a complete idiot.  She has no idea how to invest.  Look at the number. Medi up to 94 cents in feb and announcement on March 1.  You can see on short data.ca that Medipharm shorts shot up to 60 mil shorts and back dow to 20 mil or so.  Guess what hot tech woman bmo covered their short with the issue without having to increase volume and pump price up. You got played. But hey why would someone drop 20mil at .58.  It's a no brainer right.  Rookie.  To cover the short they already made 30% on. Lol. Keep going. Oh no wait.  You have.  You been buying since the 70's and 60's.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities